Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus

Clinical Biochemistry

Volumn 43, Issue 4-5, 2010, Pages 450-454

  Kaefer, Michelle ^a,b   Piva, Sílvia J ^a,b   De Carvalho, José A M ^b   Da Silva, Dievan B ^b   Becker, Aline M ^b   Coelho, Adriane C ^c   Duarte, Marta M M F ^d   Moresco, Rafael N ^a,b  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b Centro de Ciencias da Sau   (Brazil)

^c Associação dos Diabéticos de Santa Maria   (Brazil)

^d UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

Inflammation; Ischemia; Oxidative stress; Type 2 diabetes mellitus

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; GLUCOSE; GLYCOSYLATED ALBUMIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISCHEMIA MODIFIED ALBUMIN; LACTIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HUMAN; HYPERGLYCEMIA; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; UPREGULATION;

BLOOD GLUCOSE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; HYPERGLYCEMIA; INFLAMMATION; ISCHEMIA; MALE; MIDDLE AGED; SERUM ALBUMIN;

EID: 76749084277     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.11.018     Document Type: Article

References (30)

1. Wild S., Roglic G., Green A., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
2. Lebeche D., Davidoff A.J., and Hajjar R.J. Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy. Nat. Clin. Pract. Cardiovasc. Med. 5 (2008) 715-724
3. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care 32 (2009) S13-S61
4. Schramm T.K., Gislason G.H., Kober L., et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 117 (2008) 1945-1954
5. Pu L.J., Lu L., Xu X.W., et al. Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes. Cardiovasc. Diabetol. 5 (2006) 27
6. Marfella R., D'Amico M., Di Filippo C., et al. Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia 45 (2002) 1172-1181
7. Bar-Or D., Lau E., and Winkler J.V. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia: a preliminary report. J. Emerg. Med. 19 (2000) 311-315
8. Roy D., Quiles J., Gaze D.C., et al. Role of reactive oxygen species on the formation of the novel diagnostic marker ischemia modified albumin. Heart 92 (2006) 113-114
9. Cichota L.C., Moresco R.N., Duarte M.M.M.F., et al. Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease. J. Clin. Lab. Anal. 22 (2008) 1-5
10. Duarte M.M.M.F., Rocha J.B.T., Moresco R.N., et al. Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin. Biochem. 42 (2009) 666-671
11. Sinha M.K., Roy D., Gaze D.C., et al. Role of "ischemia modified albumin", a new biochemical marker of myocardial ischemia, in the early diagnosis of acute coronary syndromes. Emerg. Med. J. 21 (2004) 29-34
12. Bhagavan N.V., Lai E.M., Rios P.A., et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin. Chem. 49 (2003) 581-585
13. Montagnana M., Lippi G., Volpe A., et al. Evaluation of cardiac laboratory markers in patients with systemic sclerosis. Clin. Biochem. 39 (2006) 913-917
14. Piwowar A., Knapik-Kordecka M., and Warwas M. Ischemia modified albumin level in type 2 diabetes mellitus-preliminary report. Dis. Markers. 24 (2008) 311-317
15. Gross J.L., Azevedo M.J., Silveiro S.P., Canani L.H., Caramori M.L., and Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28 (2005) 176-188
16. Rolo A.P., and Palmeira C.M. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharmacol. 212 (2006) 167-178
17. Aronson D. Hyperglycemia and the pathobiology of diabetic complication. Adv. Cardiol. 45 (2008) 1-16
18. Goldin A., Beckman J.A., Schmidt A.M., et al. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114 (2006) 597-605
19. Bar-Or D., Rael L.T., Bar-Or R., et al. The cobalt-albumin binding assay: insights into its mode of action. Clin. Chim. Acta. 387 (2008) 120-127
20. Bar-Or D., Curtis C.G., Sullivan A., et al. Plasma albumin cysteinylation is regulated by cystathionine beta-synthase. Biochem. Biophys. Res. Commun. 325 (2004) 1449-1453
21. Yukl R.L., Bar-Or D., and Harris L. Low albumin level in the emergency department: a potential independent predictor of delayed mortality in blunt trauma. J. Emerg. Med. 25 (2003) 1-6
22. Zapico-Muñiz E., Santaló-Bel M., Mercé-Muntañola J., et al. Ischemia-modified albumin during skeletal muscle ischemia. Clin. Chem. 50 (2004) 1063-1065
23. Kamezaki F., Yamashita K., Kubara T., et al. Derivates of reactive oxygen metabolites correlates with high-sensitivity C reactive protein. J. Atheroscler. Thromb. 15 (2008) 206-212
24. Kasap S., Gönenç A., Sener D.E., et al. Serum cardiac markers in patients with acute myocardial infarction: oxidative stress, C-reactive protein and N-terminal probrain natriuretic peptide. J. Clin. Biochem. Nutr. 41 (2007) 50-57
25. Hirose H., Kawabe H., Komiya N., et al. Relation between serum reactive oxygen metabolites and metabolic parameters in a Japanese population. J. Atheroscler. Thromb. 16 (2009) 77-82
26. Wadham C., Albanese N., Roberts J., et al. High-density lipoproteins neutralize C-reactive protein proinflammatory activity. Circulation 109 (2004) 2116-2122
27. Cockerill G.W., Rye K.A., Gamble J.R., et al. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 1987-1994
28. Sampietro T., Bigazzi F., Dal Pino B., et al. Increased plasma C-reactive protein in familial hypoalphalipoproteinemia: a proinflammatory condition?. Circulation 105 (2002) 11-14
29. Motomura T., Okamoto M., and Kitamura T. Effects of pitavastatin on serum lipids and high sensitivity C-reactive protein in type 2 diabetic patients. J. Atheroscler. Thromb. 16 (2009) 1-7
30. Sinha M.K., Gaze D.C., Tippins J.R., et al. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 107 (2003) 2403-2405